Nanaomycin A
Based on 5 publication(s) in Google Scholar
Nanaomycin A is a selective DNMT3B inhibitor with an IC50 of 500 nM. Nanaomycin A inhibits the in vitro growth of human Plasmodium falciparum with an IC80 of 33.1 nM.
For research use only. We do not sell to patients.
- Purity: 98.13%
- CAS No.: 52934-83-5
- Formula: C16H14O6
- Molecular Weight:302.28
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
-
Anti-Infection Compound Library
HY-L002
-
Epigenetics Compound Library
HY-L005
-
Anti-Cancer Compound Library
HY-L025
-
Reprogramming Compound Library
HY-L039
-
Anti-Blood Cancer Compound Library
HY-L079
-
Antiparasitic Compound library
HY-L082
-
Transcription Factor-Targeted Library
HY-L090
-
Mitochondrial Toxicity Compound Library
HY-L155
-
Highly Selective Inhibitors Library
HY-L158
-
Anti-Hematopathy Compound Library
HY-L171
-
Multi-Target Compound Library
HY-L176
-
Bioactive Compound Library Max
HY-L181
-
Epigenetics Compound Library Mini
HY-L005M
-
Bioactive Compound Library
HY-L001
-
Methylation Compound Library
HY-L203
-
High-Throughput Bioactive Compound Library
HY-L205
-
Anti-Rheumatic Arthritis Compound Library
HY-L210
-
Posttranslational Modification Library
HY-L226
Publications Citing Use of MedChemExpress (MCE) Nanaomycin A
MoreAll DNA Methyltransferase Isoforms
MoreAll Parasite Isoforms
More
Biological Activity
|
DNMT3B 500 nM (IC50) |
Plasmodium |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Sf9 | IC50 |
0.5 μM
Compound: 23
|
Inhibition of His6-tagged human recombinant DNMT3b expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scinti
Inhibition of His6-tagged human recombinant DNMT3b expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scinti
|
[PMID: 25406944] |
| Vero | CC50 |
0.7 μM
Compound: Nanaomycin A
|
Cytotoxicity in African green monkey Vero cells assessed as reduction in cell viability
Cytotoxicity in African green monkey Vero cells assessed as reduction in cell viability
|
[PMID: 32435413] |
Nanaomycin A (10-10000 nM; 72 hours) exhibited significant cytotoxicity in all three cell lines[1].
Nanaomycin A (0.5-5 μM; 72 hours) induced RASSF1A protein expression in A549 cells[1].
Nanaomycin A is a selective inhibitor of DNMT3B that induces genome demethylation and does not affect the enzyme activity of DNMT1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT116 (colon), A549 (lung), and HL60 (bone marrow) human tumor cell lines
-
Concentration:10, 100, 1000, 10000 nM
-
Incubation Time:72 hours
-
Result:Had a distinct cytotoxic effect in all three cell lines.
-
Cell Line:A549 cells
-
Concentration:0.5, 5 μM
-
Incubation Time:72 hours
-
Result:Revealed induction of RASSF1A protein expression.
Chemical Information
-
CAS No. 52934-83-5
-
Appearance Solid
-
Molecular Weight 302.28
-
Formula C16H14O6
-
Color Yellow to orange
-
SMILES
O=C(O)C[C@H]1CC(C(C2=C3C(O)=CC=C2)=O)=C(C3=O)[C@H](C)O1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (5)
-
Journal Impact Factor
-
Most Recent
-
Antioxid Redox Signal
Oxidative Stress-Induced Hypermethylation of KLF5 Promoter Mediated by DNMT3B Impairs Osteogenesis by Diminishing the Interaction with β-Catenin. [Abstract]2021 Jul;35(1):1-20. PMID: 33588625 -
Cancers (Basel)
DNMT3B Controls Enhancer-Linked Chromatin and Cell Cycle Networks in Acute Myeloid Leukemia. [Abstract]2026 Feb 24;18(5):723. PMID: 41827658 -
J Biol Chem
DNMT3b-mediated CpA methylation facilitates REST binding and gene silencing and exacerbates hippocampal demyelination in diabetic mice. [Abstract]2024 Dec 25:108137. PMID: 39730060 -
-
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (480 KB)
- English - EN (480 KB)
- Français - FR (480 KB)
- Deutsch - DE (480 KB)
- Norwegian - NO (480 KB)
- Español - ES (480 KB)
- Swedish - SV (480 KB)
- Italian - IT (480 KB)
- Portuguese - PT (480 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kuck D, et al.Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells.Mol Cancer Ther. 2010 Nov;9(11):3015-23. [Content Brief]
[2]. Tanaka Y, et al.Heme-dependent radical generation: possible involvement in antimalarial action of non-peroxide microbial metabolites, nanaomycin A and radicicol.J Antibiot (Tokyo). 1999 Oct;52(10):880-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz